Using Off-Label Communications to Responsibly Advance the Public Health
11 Center for Medicine in the Public Interest, New York, NY, USA.
Abstract:
The debate over off-label communications doesn't begin or end with the Caronia or Amarin decisions. It's a continuing dialogue between manufacturers and the FDA, between doctors and patients, between doctors and academics, between lawyers and judges, and between advocates on all sides. And the red thread that ties these conversations together is responsible off-label communications. Not sales strategies. Not Direct-to-Consumer (DTC) advertising and marketing tactics. Not managed market negotiations-the responsible sharing of truthful and accurate information via nonregulated speech. Off-label communications, properly done, advances precision medicine, delivering speedier positive patient outcomes and reducing costs to our health care system. Off-label communications provides patients with more options for effective medicines.
More Related Videos
09:16Use of a Video Scoring Anchor for Rapid Serial Assessment of Social Communication in Toddlers
Published on: March 14, 2018
05:27Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
Published on: December 25, 2016
Related Concept Videos
Levels of Communication II: Organizational, Public, and Group Dynamics
Communication
Communication
Neuronal Communication
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Health Literacy
